» Articles » PMID: 37476411

As the Key Gene Related to the Co-occurrence of Sarcopenia and Osteoporosis

Overview
Journal Front Genet
Date 2023 Jul 21
PMID 37476411
Authors
Affiliations
Soon will be listed here.
Abstract

Sarcopenia and osteoporosis, two degenerative diseases in older patients, have become severe health problems in aging societies. Muscles and bones, the most important components of the motor system, are derived from mesodermal and ectodermal mesenchymal stem cells. The adjacent anatomical relationship between them provides the basic conditions for mechanical and chemical signals, which may contribute to the co-occurrence of sarcopenia and osteoporosis. Identifying the potential common crosstalk genes between them may provide new insights for preventing and treating their development. In this study, DEG analysis, WGCNA, and machine learning algorithms were used to identify the key crosstalk genes of sarcopenia and osteoporosis; this was then validated using independent datasets and clinical samples. Finally, four crosstalk genes (, , , and ) were identified, and mRNA expression and protein levels of in clinical samples from patients with sarcopenia, with osteoporosis, and with both sarcopenia and osteoporosis were found to be significantly higher than those from patients without sarcopenia or osteoporosis. seems to be a key gene related to the development of both sarcopenia and osteoporosis.

Citing Articles

Identifying Hub Genes and Metabolic Pathways in Collagen VI-Related Dystrophies: A Roadmap to Therapeutic Intervention.

Ceyhan A, Kaynar A, Altay O, Zhang C, Temel S, Turkez H Biomolecules. 2024; 14(11).

PMID: 39595553 PMC: 11592009. DOI: 10.3390/biom14111376.


Identification of shared gene signatures and pathways for diagnosing osteoporosis with sarcopenia through integrated bioinformatics analysis and machine learning.

Zhou X, Zhao L, Zhang Z, Chen Y, Chen G, Miao J BMC Musculoskelet Disord. 2024; 25(1):435.

PMID: 38831425 PMC: 11149362. DOI: 10.1186/s12891-024-07555-2.


Unraveling the intricacies of osteoclast differentiation and maturation: insight into novel therapeutic strategies for bone-destructive diseases.

Takegahara N, Kim H, Choi Y Exp Mol Med. 2024; 56(2):264-272.

PMID: 38297158 PMC: 10907717. DOI: 10.1038/s12276-024-01157-7.

References
1.
Aoki Y, Furukawa K, Suzuki D, Takayashiki T, Kuboki S, Takano S . Influence of sarcopenia as defined by EWGSOP2 on complications after pancreaticoduodenectomy and on the prognosis of pancreatic head cancer: A prospective cohort study. Nutrition. 2022; 99-100:111660. DOI: 10.1016/j.nut.2022.111660. View

2.
Buehring B, Binkley N . Myostatin--the holy grail for muscle, bone, and fat?. Curr Osteoporos Rep. 2013; 11(4):407-14. DOI: 10.1007/s11914-013-0160-5. View

3.
Noda T, Kamiya K, Hamazaki N, Nozaki K, Ichikawa T, Yamashita M . SARC-F predicts poor motor function, quality of life, and prognosis in older patients with cardiovascular disease and cognitive impairment. Exp Gerontol. 2022; 171:112021. DOI: 10.1016/j.exger.2022.112021. View

4.
Shen H, Grimston S, Civitelli R, Thomopoulos S . Deletion of connexin43 in osteoblasts/osteocytes leads to impaired muscle formation in mice. J Bone Miner Res. 2014; 30(4):596-605. PMC: 4444057. DOI: 10.1002/jbmr.2389. View

5.
Hu Z, Yang A, Tian Y, Song X . Daytime napping, comorbidity profiles, and the risk of sarcopenia in older individuals. Front Physiol. 2022; 13:1000593. PMC: 9663836. DOI: 10.3389/fphys.2022.1000593. View